Grow your own arteries - a new radical approach in CHD Gill Higgins Newsletter Article 13 February 2013 Pages: 3 - 3
The liability of limiting access to expensive biotech drugs Newsletter Article 13 February 2013 Pages: 3 - 4
SAVE, SOLVD and CONSENSUS studies open a new chapter in HF prevention Newsletter Article 13 February 2013 Pages: 4 - 4
Trimetazidine - extending the benefits of thrombolytics? Gill Higgins Newsletter Article 13 February 2013 Pages: 5 - 6
Targetting cancers with bifunctional monoclonal antibodies Newsletter Article 13 February 2013 Pages: 9 - 9
Medical treatment the best option in neurocysticercosis Newsletter Article 13 February 2013 Pages: 12 - 12
Interferon-γ has little use in childhood hepatitis B Newsletter Article 13 February 2013 Pages: 12 - 12
Multifactorial treatment strategies urged in hypertension Gill Higgins Newsletter Article 13 February 2013 Pages: 13 - 14
Vancomycin superior to cotrimoxazole in S. aureus infections Newsletter Article 13 February 2013 Pages: 14 - 14
Aspirin mainstay for silent ischaemia - the Swedish RISC group trial Newsletter Article 13 February 2013 Pages: 16 - 16
Antibody levels do not affect streptokinase/anistreplase thrombolysis Newsletter Article 13 February 2013 Pages: 19 - 19
Reanalysis of data urges a rethink on ‘Halcion’ withdrawal Newsletter Article 13 February 2013 Pages: 20 - 20